Related Experiment Video

Updated: Jun 8, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.5K

SIRT3 Inhibits Cell Proliferation of Nonsmall Cell Lung Carcinoma by Inducing ROS Production

Ze Yu1,2, Hongtao Liao3, Guanhuai Wu3

  • 1Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Zhejiang University School of Medicine, Zhoushan, Zhejiang, China.

The Clinical Respiratory Journal
|November 6, 2024
PubMed
Abstract

Insights

Sirtuin 3 (SIRT3) acts as a tumor suppressor in nonsmall cell lung carcinoma (NSCLC). Upregulating SIRT3 inhibits NSCLC cell proliferation by increasing oxidative phosphorylation and ROS production, suggesting a poor prognosis with low SIRT3 expression.

Area of Science:

  • Mitochondrial biology
  • Cancer research
  • Molecular oncology

Background:

  • Sirtuin 3 (SIRT3) is a mitochondrial matrix enzyme regulating metabolic enzyme acetylation.
  • SIRT3 can function as either an oncogene or a tumor suppressor, influencing cancer initiation and progression.
  • This study focuses on the specific role of SIRT3 in nonsmall cell lung carcinoma (NSCLC) progression.

Purpose of the Study:

  • To investigate the role of Sirtuin 3 (SIRT3) in the progression of nonsmall cell lung carcinoma (NSCLC).
  • To analyze the differential expression and prognostic significance of SIRT3 in NSCLC.
  • To elucidate the mechanisms by which SIRT3 influences NSCLC cell behavior.

Main Methods:

  • Bioinformatic analysis of SIRT3 expression, prognosis, single-cell data, and signaling pathways in NSCLC.
  • Construction of lentiviral vectors for SIRT3 overexpression.
  • Assessment of NSCLC cell proliferation using CCK8 and colony formation assays.
  • Detection of reactive oxygen species (ROS) production via flow cytometry.
  • Measurement of cellular oxygen consumption (OCR) using Seahorse assays.

Main Results:

  • SIRT3 expression is significantly decreased in NSCLC tissues compared to normal tissues.
  • Low SIRT3 expression is correlated with a poor prognosis in NSCLC patients.
  • Overexpression of SIRT3 suppressed proliferation in NSCLC cell lines (A549, SK-MES-1).
  • SIRT3 upregulation increased oxidative phosphorylation (OXPHOS) and ROS production in NSCLC cells.

Conclusions:

  • SIRT3 functions as a tumor suppressor in nonsmall cell lung carcinoma.
  • SIRT3 suppresses NSCLC progression, potentially through the stimulation of ROS production.
  • Targeting SIRT3 may represent a therapeutic strategy for NSCLC.
Keywords:
NSCLCOXPHOSROSSIRT3tumor suppressor

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K
Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

8.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K